Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer

Journal of Surgical Oncology
C William HelmMarcello Deraco

Abstract

Women with epithelial ovarian cancer (EOC) usually present with advanced disease and overall only just over half survive 5 years. Even following a complete response to front-line treatment two-thirds will recur, with a resultant dismal prognosis. We review and discuss the role of surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in EOC and present the results of the ovary consensus panel (OCP) convened for the 5th International Workshop on Peritoneal Surface Malignancy.

References

Mar 11, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M MarkmanJ L Lewis
Nov 1, 1989·British Journal of Cancer·M E GoreA H Calvert
Jan 1, 1988·Critical Reviews in Oncology/hematology·S C Rubin, J L Lewis
Sep 1, 1988·Gynecologic Oncology·K C PodratzT O Wilson
Dec 1, 1995·Radiology·R ForstnerJ L Stern
Oct 1, 1995·AJR. American Journal of Roentgenology·J I MeyerR C Zepp
Nov 18, 1993·The New England Journal of Medicine·S A Cannistra
Jun 1, 1994·Gynecologic Oncology·F Guidozzi, J H Ball
Jan 1, 1996·European Journal of Gynaecological Oncology·A OnnisL Castellan
Jun 13, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P J van de VaartA C Begg
Sep 2, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P CasaliF Cavalli
Jan 6, 2000·Annals of Surgical Oncology·P H Sugarbaker, D Chang
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F M MuggiaJ M Small
Jun 22, 2000·Journal of Surgical Oncology·F CavaliereR Cavaliere
Nov 18, 2000·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·N van der VangeJ H Beijnen
May 4, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A J WitkampF A Zoetmulder
Aug 9, 2001·Journal of the American College of Surgeons·E ChangD L Bartlett
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard R BarakatDavid Spriggs
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert E BristowF J Montz
Apr 6, 2002·Journal of Cancer Research and Clinical Oncology·J HuoberD Wallwiener
Jul 13, 2002·Expert Review of Anticancer Therapy·M Markman
Aug 23, 2002·Current Opinion in Oncology·Emery SalomRamin Mirhashemi
Mar 27, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S MemarzadehR Farias-Eisner
May 8, 2003·Annals of Surgical Oncology·Faheez MohamedPaul H Sugarbaker
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert F OzolsUNKNOWN Gynecologic Oncology Group
Oct 22, 2003·Surgical Oncology Clinics of North America·Marcello DeracoShigeki Kusamura
Dec 6, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M J PiccartJ B Vermorken
Feb 7, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M LookP H Sugarbaker
Jun 30, 2004·World Journal of Surgical Oncology·Pompiliu PisoHans Juergen Schlitt
Jul 21, 2004·Gynecologic Oncology·Nick M SpirtosPeter L Lim

❮ Previous
Next ❯

Citations

Feb 15, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Clarisse S MuenyiJ Christopher States
Dec 18, 2013·Current Treatment Options in Oncology·Ramez N EskanderRobert E Bristow
Feb 13, 2014·Toxicological Sciences : an Official Journal of the Society of Toxicology·Clarisse S MuenyiJ Christopher States
Nov 12, 2013·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·N BakrinUNKNOWN FROGHI (FRench Oncologic and Gynecologic HIPEC) Group
Jan 19, 2016·Journal of Laparoendoscopic & Advanced Surgical Techniques. Part a·Ming-Chen BaShu-Zhong Cui
Dec 14, 2011·Annales Françaises D'anesthèsie Et De Rèanimation·F-P DesgrangesV Piriou
Aug 17, 2010·Critical Reviews in Oncology/hematology·S BarniF Petrelli
May 15, 2010·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C PomelD Elias
Aug 22, 2009·Journal of Surgical Oncology·Aviram NissanPompiliu Piso
Aug 22, 2009·Journal of Surgical Oncology·Santiago González-MorenoLuis González-Bayón
Nov 30, 2010·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M DeracoS Kusamura
Feb 5, 2010·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Cyril William HelmShesh N Rai
Feb 1, 2020·Surgical Laparoscopy, Endoscopy & Percutaneous Techniques·Ming-Chen BaShu-Zhong Cui
Aug 1, 2012·Expert Review of Anticancer Therapy·Eelco de Bree, C William Helm
Apr 9, 2016·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Susana Sánchez-GarcíaJesús Martín-Fernández
Sep 3, 2020·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Martin HübnerGregg Nelson
May 27, 2021·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Huseyin AkilliAli Ayhan
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F JolyP Pautier
Dec 26, 2009·Current Opinion in Obstetrics & Gynecology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.